Clinical Trials Webinar Series - Neuroimaging Updates: Dementias and Parkinsonian Syndromes
Clinical Trials Webinar Series - Neuroimaging Updates: Dementias and Parkinsonian Syndromes

Clinical Trials Webinar Series - Neuroimaging Updates on Dementias and Parkisonian Syndromes


AMA Member Fee: $29.00
AMA Non-Member Fee: $49.00

Voice Member Fee: $20.00
Voice Non-Member Fee: $32.00


ACPE Member Fee: $24.00
ACPE Non-Member Fee: $40.00


Release date: 01-12-2015
Expiration date: 07-31-2019

Speaker

Theodore A. Henderson, MD, PhD financial disclosure is on file and has nothing to disclose

Target Audience

Physicians, pharmacists, and technologists

Objectives

At the completion of this activity, the participant will be able to:

1. List the identifying characteristics of Alzheimer?s and Parkinson?s diseases.
2. Discuss how the use of radiopharmaceuticals with PET/CT and SPECT imaging can be beneficial in managing neurological   diseases.
3. Describe how molecular imaging can significantly reduce health care costs in AD and PD.

Continuing Education Credit Information


AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 1.0
AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Release date: 01-12-15 Expiration date: 01-31-18

ACPE (Pharmacists)
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this enduring material is 0210-0000-12-304-H04-P. Total available credit for pharmacists is 1.0 hours or 0.1 CEUs. Release date: January 12, 2015; Expiration date: January 31, 2015. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation.

VOICE (Technologists)
SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 1 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment. You must obtain a score of 80% to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test. Release Date: 01-12-15 Expiration Date: 01-31-18

California Scope: 1 Radiopharmacy(R).

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/)

For questions please contact the Education Department

©2015 SNMMI. All rights reserved.

For more information on our privacy policy, please click the link below.


 

 

 

 

 


Type:     Internet Activity (Enduring Material)
18 Registered Users